Valtoco Shortage Update: What Patients Need to Know in 2026

If you've had trouble filling your Valtoco (diazepam nasal spray) prescription, you may be wondering: is Valtoco in shortage? This article covers the latest availability status as of 2026, explains why patients often struggle to find it, and gives you practical steps to take.

Is Valtoco in Shortage in 2026?

As of 2026, Valtoco is not listed on the FDA Drug Shortage Database or the ASHP Drug Shortages List. This means Valtoco does not have an active national shortage designation. However, the absence of a formal shortage listing does not mean the medication is easy to find. Many patients across the country continue to experience difficulty filling their Valtoco prescriptions because of limited pharmacy stocking, not a formal manufacturing shortage.

Why Is Valtoco Still Hard to Find If There's No Official Shortage?

A drug can be frustrating to fill even without a national shortage. In Valtoco's case, several structural factors limit availability at retail pharmacies:

Single manufacturer: Valtoco is made exclusively by Neurelis, Inc. There are no authorized generic manufacturers. Any production disruption could affect nationwide supply quickly.

No generic available: Without a generic, there's no competition-driven incentive for pharmacies to stock it in volume. Many pharmacies carry only what patients request.

Specialty medication: Valtoco is a niche seizure rescue medication. Most retail pharmacies won't stock specialty products with relatively low turnover.

Controlled substance regulations: As a Schedule IV CIV controlled substance, Valtoco requires special handling and recordkeeping, which some pharmacies prefer to avoid for low-demand medications.

Valtoco Availability: What Has Changed in Recent Years?

When Valtoco first gained FDA approval in January 2020, it was approved for patients ages 6 and older. In April 2025, the FDA expanded approval to include children ages 2 to 5, significantly broadening the potential patient population. This expansion may over time increase demand and encourage more pharmacies to stock the medication. Additionally, Neurelis now offers 5-dose packaging to better support patient care continuity.

How to Stay Ahead of Availability Issues

Here are proactive steps patients can take to avoid running out of Valtoco:

Refill early: Start the refill process when you open your current kit—not when you've used the last dose.

Establish a specialty pharmacy relationship: Use a specialty pharmacy that reliably stocks Valtoco so you're not hunting for it each time.

Enroll in myNEURELIS: The manufacturer's support program at 1-866-696-3873 can help with pharmacy access, insurance issues, and prior authorizations.

Use medfinder: medfinder calls pharmacies near you to check who has your Valtoco dose kit in stock. This saves hours of calling and helps you find the nearest available pharmacy.

Have a backup plan: Ask your neurologist whether you should have a backup rescue medication (such as Nayzilam or Diastat) available for situations where your Valtoco prescription can't be filled quickly.

Should You Worry About a Future Valtoco Shortage?

Because Valtoco is made by a single company and has no generic, a future shortage is theoretically possible if Neurelis encounters manufacturing issues, raw material disruptions, or supply chain challenges. Being proactive—keeping your prescription current and maintaining a relationship with a reliable specialty pharmacy—is your best protection.

Where to Get Help Right Now

If you're having trouble finding Valtoco at a pharmacy near you, medfinder can call pharmacies in your area on your behalf and text you results. This is the fastest way to find which pharmacy near you can fill your Valtoco prescription today.

See also: How to Find Valtoco in Stock Near You (Tools + Tips).